Intestinal glucose stimulation has anti-incretin effect

September 13, 2017

(HealthDay)—Intestinal glucose stimulation has an anti-incretin effect, down regulating insulin sensitivity, according to a study published online Aug. 29 in Diabetes.

Serenella Salinari, D.Sc., from the University of Rome "La Sapienza," and colleagues studied eight healthy volunteers and eight severely obese individuals with insulin resistance. After test and isoglycemic intravenous glucose injection, the authors measured , insulin sensitivity, rate of glucose appearance, and disposition index. Obese individuals were assessed before and after intestinal bypass (biliopancreatic diversion [BPD]).

The researchers found that insulin sensitivity was lower during oral versus intravenous glucose administration, despite isoglycemic conditions. The difference was greater in obese subjects, and declined to normal following BPD. No evidence was found for glucose malabsorption. If was not reduced by oral glucose stimulation, mathematical simulations showed that hypoglycemia would occur.

"The findings support a new model for how foodborne factors can induce insulin-resistance and provide a possible explanation for the improvement of insulin resistance/diabetes after gastrointestinal bypass surgery," the authors write.

Explore further: Adipose tissue insulin resistance up in obese-NGT, IGT, T2DM

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Adipose tissue insulin resistance up in obese-NGT, IGT, T2DM

January 9, 2017
(HealthDay)—Resistance to the antilipolytic effect of insulin (Adipo-IR) is increased in obese individuals with normal glucose tolerance (NGT), and in those with impaired glucose tolerance (IGT) and type 2 diabetes (T2DM), ...

Progression of dysglycemia in youth similar to adults

July 12, 2014
(HealthDay)—For obese adolescents, glucose sensitivity deteriorates progressively across the spectrum of glucose tolerance, according to a study published online June 19 in Diabetes.

Metabolic benefit same with similar weight loss after surgery

November 21, 2016
(HealthDay)—Early metabolic differences following laparoscopic adjustable gastric banding (LAGB) and Roux-en-Y gastric bypass (RYGB) in obese individuals with type 2 diabetes mellitus (T2DM) disappear when weight loss reaches ...

L. reuteri enrichment of gut microbiota ups insulin secretion

October 12, 2015
(HealthDay)—Enrichment of gut microbiota with Lactobacillus reuteri is associated with increased insulin secretion, according to a study published in the October issue of Diabetes Care.

Hypothalamic Lin28a shows role in glucose homeostasis

June 5, 2017
(HealthDay)—An experimental study supports a TANK-binding kinase 1 (TBK-1)-dependent role for Lin28a in the hypothalamic ventromedial nucleus in glucose homeostasis. The study was published online May 26 in Diabetes.

SFRP4 linked to impaired glucose tolerance, T2DM

August 1, 2016
(HealthDay)—Secreted frizzled-related protein 4 (SFRP4) is associated with impaired glucose tolerance (IGT) and type 2 diabetes (T2D), according to a report published online July 6 in Diabetes Care.

Recommended for you

Deep brain stimulation found to improve diabetes symptoms

May 24, 2018
A team of researchers from several institutions in the Netherlands and Yale University in the U.S. has found evidence that suggests deep brain stimulation (DBS) can help treat type 2 diabetes. In their paper published in ...

Women with pregnancy-related diabetes may be at risk for chronic kidney disease

May 21, 2018
Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears ...

Diabetes researchers find switch for fatty liver disease

May 17, 2018
Duke researchers have identified a key fork in the road for the way the liver deals with carbohydrates, fats and protein. They say it could be a promising new target for combating the pandemics of fatty liver disease and ...

New study of youth with type 1 diabetes connects 'honeymoon period' with lower LDL cholesterol

May 17, 2018
A new study by UMass Medical School physician-scientist Benjamin U. Nwosu, MD, finds that children with type 1 diabetes who experienced a partial clinical remission, or "honeymoon phase," had significantly lower low-density ...

"Living drug factories" may one day replace injections

May 17, 2018
Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections ...

Boosting the effects of vitamin D to tackle diabetes

May 10, 2018
More than 27 million people in the United States are living with type 2 diabetes, according to the Centers for Disease Control and Prevention. As the population ages and a growing percentage of people become overweight or ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.